Clorox Co. (CLX) Reaches New 12-Month High at $140.47
Clorox Co. (NYSE:CLX) shares hit a new 52-week high during trading on Wednesday . The stock traded as high as $140.47 and last traded at $138.74, with a volume of 542,979 shares trading hands. The stock had previously closed at $139.24.
Several brokerages recently commented on CLX. Zacks Investment Research cut Clorox from a “hold” rating to a “sell” rating in a research report on Tuesday. Atlantic Securities began coverage on Clorox in a research report on Tuesday, June 14th. They set a “neutral” rating and a $138.00 price target for the company. B. Riley reissued a “neutral” rating and set a $109.00 price target on shares of Clorox in a research report on Tuesday, May 10th. JPMorgan Chase & Co. raised their price objective on Clorox from $120.00 to $123.00 and gave the company an “underweight” rating in a research report on Wednesday, May 4th. Finally, Goldman Sachs Group Inc. raised their price objective on Clorox from $125.00 to $126.00 and gave the company a “neutral” rating in a research report on Tuesday, May 3rd. Four research analysts have rated the stock with a sell rating and six have given a hold rating to the stock. Clorox has an average rating of “Hold” and a consensus price target of $124.10.
The stock has a market capitalization of $17.79 billion and a price-to-earnings ratio of 26.87. The firm has a 50 day moving average of $132.52 and a 200-day moving average of $128.67.
Clorox (NYSE:CLX) last issued its earnings results on Tuesday, May 3rd. The company reported $1.21 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.10. The firm earned $1.43 billion during the quarter, compared to the consensus estimate of $1.41 billion. During the same period in the previous year, the firm earned $1.08 earnings per share. The business’s quarterly revenue was up 1.8% on a year-over-year basis. Equities analysts predict that Clorox Co. will post $4.95 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 12th. Shareholders of record on Wednesday, July 27th will be issued a dividend of $0.80 per share. This represents a $3.20 dividend on an annualized basis and a yield of 2.33%. This is a boost from Clorox’s previous quarterly dividend of $0.77. The ex-dividend date is Monday, July 25th.
In other Clorox news, COO Nikolaos A. Vlahos sold 2,151 shares of the business’s stock in a transaction that occurred on Tuesday, May 10th. The stock was sold at an average price of $132.25, for a total transaction of $284,469.75. Following the completion of the sale, the chief operating officer now directly owns 13,883 shares of the company’s stock, valued at approximately $1,836,026.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
A number of hedge funds recently modified their holdings of the company. Vanguard Group Inc. raised its stake in shares of Clorox by 2.2% in the fourth quarter. Vanguard Group Inc. now owns 12,819,276 shares of the company’s stock worth $1,625,869,000 after buying an additional 273,177 shares in the last quarter. Old Mutual Global Investors UK Ltd. bought a new stake in shares of Clorox during the fourth quarter worth approximately $15,492,000. Navellier & Associates Inc raised its stake in shares of Clorox by 4,376.5% in the fourth quarter. Navellier & Associates Inc now owns 116,614 shares of the company’s stock worth $14,790,000 after buying an additional 114,009 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of Clorox by 2.5% in the fourth quarter. Wells Fargo & Company MN now owns 3,493,620 shares of the company’s stock worth $443,096,000 after buying an additional 85,557 shares in the last quarter. Finally, Bank of Montreal Can raised its stake in shares of Clorox by 25.1% in the fourth quarter. Bank of Montreal Can now owns 331,941 shares of the company’s stock worth $42,102,000 after buying an additional 66,591 shares in the last quarter.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.